Thursday, September 30, 2021 7:48:22 AM
Not IMO. I don't think a 500 patient trial is going to cut it when the fda wants SAVA to have 2 pivotal trials of much larger numbers and has approved the protocols. I think the odds of the current anavex trial that is a year to read out of being pivotal as under 10%
Recent FLNA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 09:16:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:10:21 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:06:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:04:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:01:27 PM
